Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 67.93% is in line with its 5-year average of 65.08%, near the high end of its 5-year range (54.38%–68.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.68% above its 12-month average of 67.47%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
67.93%
GROSS MARGIN AVG TTM
67.47%
GROSS MARGIN AVG 3Y
66.45%
GROSS MARGIN AVG 5Y
65.08%
GROSS MARGIN AVG 10Y
65.11%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.68%
CURRENT VS 3Y AVG
+2.23%
CURRENT VS 5Y AVG
+4.37%
CURRENT VS 10Y AVG
+4.32%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
61.16%
median of 85 covered companies
CURRENT VS SECTOR MEDIAN
+11.06%
vs the sector median at left
Market Cap
$13.41B
Gross Margin
30.08%
TTM Avg
33.76%
3Y Avg
35.72%
5Y Avg
36.84%
Market Cap
$11.86B
Gross Margin
95.71%
TTM Avg
68.63%
3Y Avg
54.72%
5Y Avg
59.42%
Market Cap
$13.84B
Gross Margin
64.37%
TTM Avg
63.66%
3Y Avg
64.40%
5Y Avg
64.61%
Market Cap
$11.38B
Gross Margin
66.48%
TTM Avg
69.16%
3Y Avg
69.73%
5Y Avg
70.75%
Market Cap
$11.35B
Gross Margin
65.77%
TTM Avg
65.28%
3Y Avg
66.17%
5Y Avg
66.85%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Penumbra, Inc. (PEN) | $12.64B | 67.93% | 67.47% | 66.45% | 65.08% |
| Tempus AI, Inc. (TEM)vs › | $12.38B | 63.98% | 58.85% | 53.03% | 43.30% |
| Baxter International Inc. (BAX)vs › | $13.41B | 30.08% | 33.76% | 35.72% | 36.84% |
| Encompass Health Corporation (EHC)vs › | $11.86B | 95.71% | 68.63% | 54.72% | 59.42% |
| DaVita Inc. (DVA)vs › | $11.48B | 31.02% | 29.95% | 30.17% | 30.48% |
| The Cooper Companies, Inc. (COO)vs › | $13.84B | 64.37% | 63.66% | 64.40% | 64.61% |
| Exelixis, Inc. (EXEL)vs › | $13.89B | 96.48% | 96.44% | 96.31% | 96.33% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 66.48% | 69.16% | 69.73% | 70.75% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 65.77% | 65.28% | 66.17% | 66.85% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 68.55% | 63.16% | 66.39% | 68.84% |
Gross Margin
67.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 67.93% |
| 2026-03-31 | 67.62% |
| 2025-12-31 | 68.02% |
| 2025-09-30 | 67.78% |
| 2025-06-30 | 65.99% |
| 2025-03-31 | 66.60% |
| 2024-12-31 | 66.79% |
| 2024-09-30 | 66.54% |
| 2024-06-30 | 54.38% |
| 2024-03-31 | 65.00% |
| 2023-12-31 | 65.69% |
| 2023-09-30 | 65.59% |
| 2023-06-30 | 63.81% |
| 2023-03-31 | 62.58% |
| 2022-12-31 | 62.58% |
| 2022-09-30 | 63.33% |
| 2022-06-30 | 64.33% |
| 2022-03-31 | 62.49% |
| 2021-12-31 | 61.49% |
| 2021-09-30 | 63.07% |
| 2021-06-30 | 64.41% |
| 2021-03-31 | 65.80% |
| 2020-12-31 | 56.51% |
| 2020-09-30 | 60.18% |
| 2020-06-30 | 61.77% |
| 2020-03-31 | 64.09% |
| 2019-12-31 | 67.55% |
| 2019-09-30 | 68.81% |
| 2019-06-30 | 69.99% |
| 2019-03-31 | 65.33% |
| 2018-12-31 | 65.16% |
| 2018-09-30 | 67.09% |
| 2018-06-30 | 65.90% |
| 2018-03-31 | 64.81% |
| 2017-12-31 | 66.35% |
| 2017-09-30 | 65.28% |
| 2017-06-30 | 63.20% |
| 2017-03-31 | 65.16% |
| 2016-12-31 | 63.72% |
| 2016-09-30 | 63.81% |
| 2016-06-30 | 63.70% |
| 2016-03-31 | 68.90% |
| 2015-12-31 | 67.00% |
| 2015-09-30 | 66.44% |
| 2015-06-30 | 64.70% |
| 2015-03-31 | 68.62% |
| 2014-12-31 | 67.48% |
| 2014-09-30 | 64.06% |
| 2014-06-30 | 65.76% |
| 2014-03-31 | 66.71% |
